Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jan 19, 2024	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001784606-24-000004.pdf 0001784606-24-000004.rtf 0001784606-24-000004.xls
Jan 19, 2024	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001784606-24-000006.pdf 0001784606-24-000006.rtf 0001784606-24-000006.xls
Jan 19, 2024	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001784606-24-000008.pdf 0001784606-24-000008.rtf 0001784606-24-000008.xls
Jan 19, 2024	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001784606-24-000010.pdf 0001784606-24-000010.rtf 0001784606-24-000010.xls
Jan 19, 2024	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001784606-24-000012.pdf 0001784606-24-000012.rtf 0001784606-24-000012.xls
Jan 08, 2024	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-24-003910.pdf 0001193125-24-003910.rtf 0001193125-24-003910.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 15, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-23-295943.pdf 0001193125-23-295943.rtf 0001193125-23-295943.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 06, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000108.pdf 0001765581-23-000108.rtf 0001765581-23-000108.xls
Dec 06, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000110.pdf 0001765581-23-000110.rtf 0001765581-23-000110.xls
Nov 14, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000106.pdf 0001765581-23-000106.rtf 0001765581-23-000106.xls

Data provided by Kaleidoscope.